Develops cpDNA markers for species authentication in Myristica, indicating vital measures against yield loss.
Late-phase graft incompatibility and subsequent yield reduction pose significant threats to sustainable nutmeg ( Myristica fragrans ) production in India, primarily due to the widespread use of wild Myristica species as rootstocks. Accurate rootstock authentication at the seedling stage is critical to prevent these long-term losses, but current methodologies are insufficient. This study develops novel chloroplast DNA (cpDNA)-based markers for species authentication and phylogenetic analysis in Myristica . Utilizing a comparative chloroplast genomics approach, we identified hypervariable regions to create robust sequence length polymorphism markers. Marker validation across 33 diverse Myristica accessions, including all major Indian cultivated germplasm, revealed a unique 25 bp deletion in the ycf4-cemA region. This deletion serves as a highly reliable diagnostic marker to differentiate cultivated nutmeg from wild rootstock species. The validated markers were successfully used to authenticate rootstocks in both commercial nurseries and established plantations, offering a critical tool to prevent long-term graft incompatibility. Intraspecific variation within M. fragrans cultivars was observed in the rpoB_trnC-GCA, trnS-UGA _ psbZ and trnR-ACG_rrn5S intergenic spacer regions. UPGMA clustering distinctly separated the Myristica accessions into three discrete phylogenetic groups. Beyond rootstock management, the identified M. fragrans -specific marker can reliably authenticate nutmeg in commercial products, distinguishing it from potential adulterants like M. magnifica and M. andamanica . Furthermore, we report a species-specific marker for the endemic and IUCN red-listed vulnerable species, M. andamanica , which will be invaluable for its precise identification and conservation efforts. Our research provides an invaluable, easy-to-use toolkit for Myristica germplasm management, breeding programs and quality control of nutmeg products.
No takes yet. Share an insight, caveat, or question.
P. et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: